Chicago-based Cresco Labs said it is buying Tryke, a vertically integrated private cannabis company active in Nevada and Arizona, for $282.5 million.
Here are the basics around the announcement:
- The $282.5 million price tag is made up of $55 million in cash and the balance in stock.
- Tryke posted revenue of $70.4 million in fiscal 2018.
- Tryke owns the Reef Dispensary brand, which includes six stores in Las Vegas and Phoenix.
- There also are cultivation facilities in the deal in both Nevada and Arizona.
Cresco, a major multistate cannabis operator, also will gain access to another state market – Utah – where Tryke has one of just eight cultivation licenses.
Cresco said it expects the deal to close in the first half of 2020, noting that it will likely be subject to U.S. Department of Justice scrutiny under Hart-Scott-Rodino antitrust measures.
It currently has another acquisition, Canadian-based distributor Origin House, also under such scrutiny.
That deal is expected to close by October 31.
More details on the Tryke acquisition can be found here.
Cresco trades on the Canadian Securities Exchange under the ticker symbol CL.
For analysis and in-depth looks at the investment trends and deals driving the cannabis industry forward, sign up for our premium subscription service, Investor Intelligence.